You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

leflunomide

Showing 1 - 25 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)

Recruiting
  • Idiopathic Pulmonary Hemosiderosis
  • Leflunomide
  • Leflunomide
  • Steroid Drug
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023

Henoch-Schonlein Purpura Trial in Guangzhou (Leflunomide)

Recruiting
  • Henoch-Schonlein Purpura
  • Leflunomide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 1, 2023

Autoimmune Diseases Trial in Beijing (Prednisone and Mycophenolate Mofetil, Mycophenolate Mofetil, Leflunomide)

Recruiting
  • Autoimmune Diseases
  • Prednisone and Mycophenolate Mofetil
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Mar 16, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

Recruiting
  • Acute Graft Versus Host Disease
  • Hematopoietic and Lymphoid System Neoplasm
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2023

PTEN-null Advanced Solid Tumors Trial in New York (Leflunomide)

Not yet recruiting
  • PTEN-null Advanced Solid Tumors
  • Leflunomide
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 8, 2022

Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

Recruiting
  • Chronic Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • Leflunomide
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Recurrent Lymphoproliferative Disorder, Refractory Lymphoproliferative Disorder Trial in Duarte (Leflunomide)

Active, not recruiting
  • Recurrent Lymphoproliferative Disorder
  • Refractory Lymphoproliferative Disorder
  • Leflunomide
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Myasthenia Gravis Trial in GuangZhou (Azathioprine, Leflunomide)

Completed
  • Myasthenia Gravis
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital, SUN YAT-SEN UNIVERSITY
Apr 6, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Laboratory Biomarker Analysis, Leflunomide,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Oct 4, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Dexamethasone, Leflunomide, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Duarte, California
    City of Hope Medical Center
Jan 10, 2022

COVID-19 Trial in Chertsey (leflunomide)

Active, not recruiting
  • COVID-19
  • leflunomide
  • Chertsey, United Kingdom
    Ashford and St Peters Hospital NHS Foundation Trust
Aug 12, 2021

Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Methotrexate, Adalimumab Injection)

Recruiting
  • Arthritis, Rheumatoid
  • Jinan, Shandong, China
    Qilu Hospital
Nov 28, 2022

ANCA Associated Vasculitis, Maintenance Therapy Trial in China (Leflunomide, Azathioprine Tablets)

Recruiting
  • ANCA Associated Vasculitis
  • Maintenance Therapy
  • Leflunomide
  • Azathioprine Tablets
  • Hefei, Anhui, China
  • +3 more
Nov 26, 2021

Rheumatoid Arthritis Trial in Omaha (Leflunomide, Methotrexate-Sulfasalazine-Hydroxychloroquine,

Completed
Has Results
  • Rheumatoid Arthritis
  • Leflunomide
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jan 14, 2021

Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Pondicherry, India
    Department of Clinical Immunology , Jawaharlal Institute of Post
Jul 25, 2021

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

COVID-19 Trial in Chicago (Leflunomide)

Unknown status
  • COVID-19
  • Leflunomide
  • Chicago, Illinois
    University of Chicago
Oct 27, 2020

Psoriatic Arthritis Trial in Oxford (Methotrexate, Sulfasalazine, Leflunomide)

Completed
Has Results
  • Psoriatic Arthritis
  • Oxford, Oxfordshire, United Kingdom
    Oxford University Hospitals NHS Trust
May 7, 2021

Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)

Recruiting
  • Rheumatoid Arthritis
  • Omaha, Nebraska
    University of Nebraska Medical Center
Oct 28, 2021

The Registry Study of Takayasu Arteritis in East China

Recruiting
  • Takayasu Arteritis
  • +4 more
  • Tocilizumab
  • Leflunomide
  • Shanghai, Shanghai, China
    Department of Rheumatology in Zhongshan hospital, Fudan Universi
Aug 7, 2021

(CHOIR)

Recruiting
  • Chronic Nonbacterial Osteomyelitis
  • Chronic Recurrent Multifocal Osteomyelitis
  • Seattle, Washington
    Seattle Children's Hospital
Jan 25, 2021

Smoldering Plasma Cell Myeloma Trial in Duarte (Leflunomide, Quality-of-Life Assessment, Questionnaire Administration)

Withdrawn
  • Smoldering Plasma Cell Myeloma
  • Leflunomide
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 12, 2019

Rheumatoid Arthritis Trial in Chicago (Lab Work, Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of

Completed
  • Rheumatoid Arthritis
  • Lab Work
  • +11 more
  • Chicago, Illinois
    Outpatient Care Center
Jul 13, 2020

Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)

Completed
  • Rheumatoid Arthritis
  • Pondicherry, Pondicherry UT, India
    Jawaharlal Institute of Postgraduate Medical Education & Researc
Sep 28, 2019